| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/BBRC.1998.9826 |
| P698 | PubMed publication ID | 9918777 |
| P2093 | author name string | S T Weintraub | |
| A M Shepherd | |||
| D X Tan | |||
| R J Reiter | |||
| Vijayalaxmi | |||
| L C Manchester | |||
| L J Hardies | |||
| B F Plummer | |||
| P433 | issue | 3 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 614-620 | |
| P577 | publication date | 1998-12-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation | |
| P478 | volume | 253 |
| Q73399761 | 5-methoxytryptophol preserves hepatic microsomal membrane fluidity during oxidative stress |
| Q44277556 | 6-Hydroxymelatonin converts Fe (III) to Fe (II) and reduces iron-induced lipid peroxidation |
| Q36513111 | A metabolomic perspective of melatonin metabolism in the mouse |
| Q89659975 | ABTS/PP Decolorization Assay of Antioxidant Capacity Reaction Pathways |
| Q38221495 | Action of melatonin on squamous cell carcinoma and other tumors of the oral cavity (Review). |
| Q83611977 | Ameliorative action of melatonin on oxidative damage induced by atrazine toxicity in rat erythrocytes |
| Q22306050 | Antioxidative Protection by Melatonin: Multiplicity of Mechanisms from Radical Detoxification to Radical Avoidance |
| Q73215103 | Augmentation of indices of oxidative damage in life-long melatonin-deficient rats |
| Q39160691 | Chromium(III)-induced 8-hydroxydeoxyguanosine in DNA and its reduction by antioxidants: comparative effects of melatonin, ascorbate, and vitamin E. |
| Q32145214 | Comparison of the protective effect of melatonin with other antioxidants in the hamster kidney model of estradiol-induced DNA damage. |
| Q44187167 | Decreased nocturnal melatonin levels during acute myocardial infarction |
| Q58725798 | Dietary Melatonin Supplementation Could Be a Promising Preventing/Therapeutic Approach for a Variety of Liver Diseases |
| Q42521327 | Dietary melatonin selectively reverses age-related changes in cortical cytokine mRNA levels, and their responses to an inflammatory stimulus |
| Q42127267 | Effect of chronic L-dopa or melatonin treatments after dopamine deafferentation in rats: dyskinesia, motor performance, and cytological analysis. |
| Q43264206 | Effect of melatonin in the antioxidant defense system in the locomotor muscles of the estuarine crab Neohelice granulata (Decapoda, Brachyura). |
| Q46576799 | Effects of hypoxia and reoxygenation on the antioxidant defense system of the locomotor muscle of the crab Neohelice granulata (Decapoda, Varunidae). |
| Q22305604 | Fundamental issues related to the origin of melatonin and melatonin isomers during evolution: relation to their biological functions |
| Q44251425 | Further insights into the reaction of melatonin with hydroxyl radical |
| Q44130673 | Hepatic mitochondrial dysfunction in senescence-accelerated mice: correction by long-term, orally administered physiological levels of melatonin |
| Q37823548 | Hepatoprotective actions of melatonin: possible mediation by melatonin receptors |
| Q34506503 | High physiological levels of melatonin in the bile of mammals |
| Q59489066 | Identification of highly elevated levels of melatonin in bone marrow: its origin and significance |
| Q37204822 | Identify Melatonin as a Novel Therapeutic Reagent in the Treatment of 1-Bromopropane(1-BP) Intoxication |
| Q73310231 | Inhibitory effects of melatonin on ferric nitrilotriacetate-induced lipid peroxidation and oxidative DNA damage in the rat kidney |
| Q44380563 | Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. |
| Q37158649 | Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats |
| Q39443537 | Melatonin ameliorates oxidative stress and induces cellular proliferation of lymphoid tissues of a tropical rodent, Funambulus pennanti, during reproductively active phase |
| Q33838766 | Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy |
| Q36282830 | Melatonin and Parkinson's disease |
| Q34416921 | Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value |
| Q59489061 | Melatonin and its derivatives cyclic 3-hydroxymelatonin, N1-acetyl-N2-formyl-5-methoxykynuramine and 6-methoxymelatonin reduce oxidative DNA damage induced by Fenton reagents |
| Q44446639 | Melatonin and pinoline prevent aluminium-induced lipid peroxidation in rat synaptosomes |
| Q24648452 | Melatonin and structurally-related compounds protect synaptosomal membranes from free radical damage |
| Q38022179 | Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes |
| Q44120560 | Melatonin attenuates brain mitochondria DNA damage induced by potassium cyanide in vivo and in vitro |
| Q34359618 | Melatonin combats molecular terrorism at the mitochondrial level |
| Q73308716 | Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation |
| Q43930997 | Melatonin improves deferoxamine antioxidant activity in protecting against lipid peroxidation caused by hydrogen peroxide in rat brain homogenates |
| Q26765826 | Melatonin in Plants - Diversity of Levels and Multiplicity of Functions |
| Q36040915 | Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment. |
| Q35001051 | Melatonin in mitochondrial dysfunction and related disorders |
| Q30476606 | Melatonin metabolism in the central nervous system |
| Q43593648 | Melatonin prevents delta-aminolevulinic acid-induced oxidative DNA damage in the presence of Fe2+. |
| Q44604274 | Melatonin protects against pro‐oxidant enzymes and reduces lipid peroxidation in distinct membranes induced by the hydroxyl and ascorbyl radicals and by peroxynitrite |
| Q35916483 | Melatonin protects lung mitochondria from aging |
| Q44034625 | Melatonin reduces memory changes and neural oxidative damage in mice treated with D-galactose |
| Q43992290 | Melatonin reduces oxidative damage of neural lipids and proteins in senescence-accelerated mouse |
| Q59489064 | Melatonin reduces oxidative neurotoxicity due to quinolinic acid: |
| Q73222977 | Melatonin reduces phenylhydrazine-induced oxidative damage to cellular membranes: evidence for the involvement of iron |
| Q73103741 | Melatonin reduces rat hepatic macromolecular damage due to oxidative stress caused by delta-aminolevulinic acid |
| Q44558496 | Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication |
| Q53101536 | Melatonin transport into mitochondria. |
| Q44066530 | Melatonin's unique radical scavenging properties - roles of its functional substituents as revealed by a comparison with its structural analogs |
| Q24815611 | Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug |
| Q62071833 | Melatonin: A Versatile Protector against Oxidative DNA Damage |
| Q37755679 | Melatonin: a multitasking molecule |
| Q35145596 | Melatonin: clinical relevance |
| Q44604277 | Melatonin: structural characterization of its non-enzymatic mono-oxygenate metabolite |
| Q37898562 | Mitochondrial DNA and inflammatory diseases. |
| Q22241837 | Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development |
| Q37007219 | Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases. |
| Q22305781 | Neurotoxins: free radical mechanisms and melatonin protection |
| Q44530239 | Oxidation of melatonin by singlet molecular oxygen (O2(1deltag)) produces N1-acetyl-N2-formyl-5-methoxykynurenine |
| Q34348724 | Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury |
| Q44288274 | Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia |
| Q44340064 | Preventive effect of melatonin on the progression of alpha-naphthylisothiocyanate-induced acute liver injury in rats |
| Q73109141 | Protective effect of beta-carbolines and other antioxidants on lipid peroxidation due to hydrogen peroxide in rat brain homogenates |
| Q44462680 | Protective effect of melatonin against mitochondrial injury induced by ischemia and reperfusion of rat liver |
| Q73133376 | Protective effects of melatonin against oxidation of guanine bases in DNA and decreased microsomal membrane fluidity in rat liver induced by whole body ionizing radiation |
| Q28387506 | Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure |
| Q34667176 | Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin |
| Q28081936 | Regulatory roles of serotonin and melatonin in abiotic stress tolerance in plants |
| Q44086407 | Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat. |
| Q59489068 | Role of pinoline and melatonin in stabilizing hepatic microsomal membranes against oxidative stress |
| Q46257143 | Taxon- and Site-Specific Melatonin Catabolism |
| Q35027014 | The chemistry of melatonin's interaction with reactive species |
| Q35276597 | Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection |
| Q30320762 | Transformation of barbituric acid into alloxan by hydroxyl radicals: interaction with melatonin and with other hydroxyl radical scavengers. |
| Q34567568 | Urinary metabolites and antioxidant products of exogenous melatonin in the mouse |
| Q43574368 | Weak vasoconstrictor activity of melatonin in human umbilical artery: relation to nitric oxide-scavenging action |
Search more.